FAD/NADH Dependent Oxidoreductases: From Different Amino Acid Sequences to Similar Protein Shapes for Playing an Ancient Function

Flavoprotein oxidoreductases are members of a large protein family of specialized dehydrogenases, which include type II NADH dehydrogenase, pyridine nucleotide-disulphide oxidoreductases, ferredoxin-NAD+ reductases, NADH oxidases, and NADH peroxidases, playing a crucial role in the metabolism of several prokaryotes and eukaryotes. Although several studies have been performed on single members or protein subgroups of flavoprotein oxidoreductases, a comprehensive analysis on structure–function relationships among the different members and subgroups of this great dehydrogenase family is still missing. Here, we present a structural comparative analysis showing that the investigated flavoprotein oxidoreductases have a highly similar overall structure, although the investigated dehydrogenases are quite different in functional annotations and global amino acid composition. The different functional annotation is ascribed to their participation in species-specific metabolic pathways based on the same biochemical reaction, i.e., the oxidation of specific cofactors, like NADH and FADH2. Notably, the performed comparative analysis sheds light on conserved sequence features that reflect very similar oxidation mechanisms, conserved among flavoprotein oxidoreductases belonging to phylogenetically distant species, as the bacterial type II NADH dehydrogenases and the mammalian apoptosis-inducing factor protein, until now retained as unique protein entities in Bacteria/Fungi or Animals, respectively. Furthermore, the presented computational analyses will allow consideration of FAD/NADH oxidoreductases as a possible target of new small molecules to be used as modulators of mitochondrial respiration for patients affected by rare diseases or cancer showing mitochondrial dysfunction, or antibiotics for treating bacterial/fungal/protista infections.

[1]  E. Parker,et al.  'Tethering' fragment-based drug discovery to identify inhibitors of the essential respiratory membrane protein type II NADH dehydrogenase. , 2018, Bioorganic & medicinal chemistry letters.

[2]  A. Vinogradov,et al.  Oxidation of NADH and ROS production by respiratory complex I. , 2016, Biochimica et biophysica acta.

[3]  G. Parisi,et al.  Molecular modeling of antibodies for the treatment of TNF α‐related immunological diseases , 2016, Pharmacology research & perspectives.

[4]  A. Puustinen,et al.  The structure of the ubiquinol oxidase from Escherichia coli and its ubiquinone binding site , 2000, Nature Structural Biology.

[5]  T. Fukui,et al.  Characterization and gene deletion analysis of four homologues of group 3 pyridine nucleotide disulfide oxidoreductases from Thermococcus kodakarensis , 2014, Extremophiles.

[6]  B. Herguedas,et al.  Structural insights into the coenzyme mediated monomer-dimer transition of the pro-apoptotic apoptosis inducing factor. , 2014, Biochemistry.

[7]  Wenfei Li,et al.  Structural insight into the type-II mitochondrial NADH dehydrogenases , 2012, Nature.

[8]  C. Jackson,et al.  FAD-sequestering proteins protect mycobacteria against hypoxic and oxidative stress , 2018, The Journal of Biological Chemistry.

[9]  V. Emmanuele,et al.  Emerging therapies for mitochondrial diseases. , 2018, Essays in biochemistry.

[10]  P. Neufer,et al.  Pyruvate dehydrogenase complex and nicotinamide nucleotide transhydrogenase constitute an energy-consuming redox circuit. , 2015, The Biochemical journal.

[11]  Robert W. Taylor,et al.  Recent Advances in Mitochondrial Disease. , 2017, Annual review of genomics and human genetics.

[12]  Ville R. I. Kaila,et al.  Correlating kinetic and structural data on ubiquinone binding and reduction by respiratory complex I , 2017, Proceedings of the National Academy of Sciences.

[13]  H. Schägger Respiratory chain supercomplexes of mitochondria and bacteria. , 2002, Biochimica et biophysica acta.

[14]  Severe Acute Respiratory Failure in Healthy Adolescents Exposed to Trimethoprim-Sulfamethoxazole , 2019, Pediatrics.

[15]  J. Archibald,et al.  Endosymbiosis and Eukaryotic Cell Evolution , 2015, Current Biology.

[16]  Annabel E. Todd,et al.  Evolution of function in protein superfamilies, from a structural perspective. , 2001, Journal of molecular biology.

[17]  L. Engstrand,et al.  Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Daisuke Kihara,et al.  A global map of the protein shape universe , 2019, PLoS Comput. Biol..

[19]  V. Pertegato,et al.  Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells , 2012, Nature Protocols.

[20]  H. Jacobs,et al.  Alternative respiratory chain enzymes: Therapeutic potential and possible pitfalls. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[21]  J. Kuriyan,et al.  Convergent evolution of similar function in two structurally divergent enzymes , 1991, Nature.

[22]  T. Yagi,et al.  The structure of the yeast NADH dehydrogenase (Ndi1) reveals overlapping binding sites for water- and lipid-soluble substrates , 2012, Proceedings of the National Academy of Sciences.

[23]  D. Linseman,et al.  Stable over‐expression of the 2‐oxoglutarate carrier enhances neuronal cell resistance to oxidative stress via Bcl‐2‐dependent mitochondrial GSH transport , 2014, Journal of neurochemistry.

[24]  Filipe M. Sousa,et al.  The key role of glutamate 172 in the mechanism of type II NADH:quinone oxidoreductase of Staphylococcus aureus. , 2017, Biochimica et biophysica acta. Bioenergetics.

[25]  Chi‐Huey Wong,et al.  Lipoamide channel-binding sulfonamides selectively inhibit mycobacterial lipoamide dehydrogenase. , 2013, Biochemistry.

[26]  Seung Chul Shin,et al.  Structure and catalytic mechanism of monodehydroascorbate reductase, MDHAR, from Oryza sativa L. japonica , 2016, Scientific Reports.

[27]  N. Čėnas,et al.  Redox reactions of the FAD-containing apoptosis-inducing factor (AIF) with quinoidal xenobiotics: a mechanistic study. , 2011, Archives of biochemistry and biophysics.

[28]  G. Kroemer,et al.  Apoptosis-inducing factor: vital and lethal. , 2006, Trends in cell biology.

[29]  Geoffrey J. Barton,et al.  Jalview Version 2—a multiple sequence alignment editor and analysis workbench , 2009, Bioinform..

[30]  A. Baykov,et al.  Flavin transferase: the maturation factor of flavin-containing oxidoreductases. , 2018, Biochemical Society transactions.

[31]  C. Duckett,et al.  Apoptosis-Inducing Factor Is a Target for Ubiquitination through Interaction with XIAP , 2007, Molecular and Cellular Biology.

[32]  J. W. Peters,et al.  Structural basis for CO2 fixation by a novel member of the disulfide oxidoreductase family of enzymes, 2-ketopropyl-coenzyme M oxidoreductase/carboxylase. , 2002, Biochemistry.

[33]  J. Locasale,et al.  The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.

[34]  E. Picardi,et al.  Rhodobacter sphaeroides adaptation to high concentrations of cobalt ions requires energetic metabolism changes. , 2014, FEMS microbiology ecology.

[35]  Jing Xu,et al.  Deficiency of Mitochondrial Glycerol 3‐Phosphate Dehydrogenase Contributes to Hepatic Steatosis , 2019, Hepatology.

[36]  V. Popov,et al.  Structure of the flavocytochrome c sulfide dehydrogenase associated with the copper-binding protein CopC from the haloalkaliphilic sulfur-oxidizing bacterium Thioalkalivibrio paradoxusARh 1. , 2018, Acta crystallographica. Section D, Structural biology.

[37]  M. Nei,et al.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. , 2011, Molecular biology and evolution.

[38]  Giovanna Ilaria Passeri,et al.  Nitro-substituted tetrahydroindolizines and homologs: Design, kinetics, and mechanism of α-glucosidase inhibition. , 2017, Bioorganic & medicinal chemistry letters.

[39]  C. Vilchèze,et al.  Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity. , 2018, Angewandte Chemie.

[40]  V. Mootha,et al.  Complementation of mitochondrial electron transport chain by manipulation of the NAD+/NADH ratio , 2016, Science.

[41]  G. Cook,et al.  Targeting bacterial energetics to produce new antimicrobials. , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[42]  M. Esposti Inhibitors of NADH-ubiquinone reductase: an overview. , 1998 .

[43]  E. Nakamaru-Ogiso,et al.  Apoptosis-inducing Factor (AIF) and Its Family Member Protein, AMID, Are Rotenone-sensitive NADH:Ubiquinone Oxidoreductases (NDH-2)* , 2015, The Journal of Biological Chemistry.

[44]  R. Yolken,et al.  Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis , 2012, Proceedings of the National Academy of Sciences.

[45]  G. Kroemer,et al.  NADH Oxidase Activity of Mitochondrial Apoptosis-inducing Factor* , 2001, The Journal of Biological Chemistry.

[46]  A. De Grassi,et al.  Prediction of high- and low-affinity quinol-analogue-binding sites in the aa3 and bo3 terminal oxidases from Bacillus subtilis and Escherichia coli1. , 2014, The Biochemical journal.

[47]  Vito Porcelli,et al.  Computational approaches for protein function prediction: a combined strategy from multiple sequence alignment to molecular docking-based virtual screening. , 2010, Biochimica et biophysica acta.

[48]  G. Kroemer,et al.  AIF: Not Just an Apoptosis‐Inducing Factor , 2009, Annals of the New York Academy of Sciences.

[49]  E. Verdin NAD+ in aging, metabolism, and neurodegeneration , 2015, Science.

[50]  Meenakshi Singh,et al.  Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery , 2017, Expert opinion on therapeutic targets.

[51]  G. Vriend,et al.  Rubredoxin reductase of Pseudomonas oleovorans. Structural relationship to other flavoprotein oxidoreductases based on one NAD and two FAD fingerprints. , 1990, Journal of molecular biology.

[52]  M. Zeviani,et al.  Mitochondrial disorders. , 2004, Brain : a journal of neurology.

[53]  Patrícia N. Refojo,et al.  Structural basis for energy transduction by respiratory alternative complex III , 2018, Nature Communications.

[54]  K. Mihara,et al.  Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space , 2005, The EMBO journal.

[55]  P. Bénit,et al.  AIF deficiency compromises oxidative phosphorylation , 2004, The EMBO journal.

[56]  T. Yagi,et al.  Ubiquinone binding site of yeast NADH dehydrogenase revealed by structures binding novel competitive- and mixed-type inhibitors , 2018, Scientific Reports.

[57]  L. Anelli,et al.  A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome , 2018, Leukemia & lymphoma.

[58]  S. Pervaiz,et al.  Reactive oxygen species and the mitochondrial signaling pathway of cell death. , 2005, Histology and histopathology.

[59]  Yuexin Li,et al.  Quinolone-3-Diarylethers: A New Class of Antimalarial Drug , 2013, Science Translational Medicine.

[60]  J. Hirst Open questions: respiratory chain supercomplexes—why are they there and what do they do? , 2018, BMC Biology.

[61]  R. P. Ross,et al.  Molecular cloning and analysis of the gene encoding the NADH oxidase from Streptococcus faecalis 10C1. Comparison with NADH peroxidase and the flavoprotein disulfide reductases. , 1992, Journal of molecular biology.

[62]  David T. Jones,et al.  pGenTHREADER and pDomTHREADER: new methods for improved protein fold recognition and superfamily discrimination , 2009, Bioinform..

[63]  G. La Piana,et al.  Proton translocation linked to the activity of the bi-trans-membrane electron transport chain. , 1995, Archives of biochemistry and biophysics.

[64]  C. Orengo,et al.  Evolution of protein function, from a structural perspective. , 1999, Current opinion in chemical biology.

[65]  A. De Grassi,et al.  AGC1/2, the mitochondrial aspartate-glutamate carriers. , 2016, Biochimica et biophysica acta.

[66]  A. De Grassi,et al.  Single-nucleotide evolution quantifies the importance of each site along the structure of mitochondrial carriers , 2013, Cellular and Molecular Life Sciences.

[67]  C. Kozany,et al.  Mia40, a novel factor for protein import into the intermembrane space of mitochondria is able to bind metal ions , 2005, FEBS letters.

[68]  J. Hirst,et al.  The mechanism of catalysis by type-II NADH:quinone oxidoreductases , 2017, Scientific Reports.

[69]  Maojun Yang,et al.  Target Elucidation by Cocrystal Structures of NADH-Ubiquinone Oxidoreductase of Plasmodium falciparum (PfNDH2) with Small Molecule To Eliminate Drug-Resistant Malaria. , 2017, Journal of medicinal chemistry.

[70]  J. Qian,et al.  A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1 , 2016, Science.

[71]  G. Kroemer,et al.  Mitochondria, the killer organelles and their weapons , 2002, Journal of cellular physiology.

[72]  M. Björnstedt,et al.  Reduction of ubiquinone by lipoamide dehydrogenase. An antioxidant regenerating pathway. , 2001, European journal of biochemistry.

[73]  V. Iacobazzi,et al.  Metabolic routes in inflammation: the citrate pathway and its potential as therapeutic target. , 2020, Current medicinal chemistry.

[74]  G. Degliesposti,et al.  Atomic structure of the entire mammalian mitochondrial complex I , 2016, Nature.

[75]  K. Kataoka,et al.  Studies of interaction of homo-dimeric ferredoxin-NAD(P)+ oxidoreductases of Bacillus subtilis and Rhodopseudomonas palustris, that are closely related to thioredoxin reductases in amino acid sequence, with ferredoxins and pyridine nucleotide coenzymes. , 2009, Biochimica et biophysica acta.

[76]  J. Prehn,et al.  Apoptosis-Inducing Factor (AIF) in Physiology and Disease: The Tale of a Repented Natural Born Killer , 2018, EBioMedicine.

[77]  K. Read,et al.  2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization , 2018, ACS infectious diseases.

[78]  Jennifer B Dennison,et al.  Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells , 2013, Cancer & Metabolism.

[79]  A. Vaidya,et al.  Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria , 2016, Antimicrobial Agents and Chemotherapy.

[80]  M. F. Hossain,et al.  SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency , 2018, Human molecular genetics.

[81]  I. Bertini,et al.  MIA40 is an oxidoreductase that catalyzes oxidative protein folding in mitochondria , 2009, Nature Structural &Molecular Biology.

[82]  A. Azzariti,et al.  Cytochrome c Is Released from Mitochondria in a Reactive Oxygen Species (ROS)-dependent Fashion and Can Operate as a ROS Scavenger and as a Respiratory Substrate in Cerebellar Neurons Undergoing Excitotoxic Death* , 2000, The Journal of Biological Chemistry.

[83]  Gregory R Bowman,et al.  Advanced Methods for Accessing Protein Shape-Shifting Present New Therapeutic Opportunities. , 2019, Trends in biochemical sciences.

[84]  G. Inesi Molecular features of copper binding proteins involved in copper homeostasis , 2017, IUBMB life.

[85]  G. Kroemer,et al.  The mitochondrion in apoptosis: how Pandora's box opens , 2001, Nature Reviews Molecular Cell Biology.

[86]  J. Smeitink,et al.  KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery , 2018, Scientific Reports.

[87]  E. Baker,et al.  Structure of the bacterial type II NADH dehydrogenase: a monotopic membrane protein with an essential role in energy generation , 2014, Molecular microbiology.

[88]  C. E. Bullerwell,et al.  Evolution of the mitochondrial genome: protist connections to animals, fungi and plants. , 2004, Current opinion in microbiology.